Abstract
The aim of the study was to investigate the feasibility of Epidermal Growth Factor Receptor (EGFR) measurement in bladder washings of patients affected by non-muscle-invasive bladder cancer (NMIBC) and its prognostic role in identifying risk subgroups and predicting disease recurrence and progression.
Lingua originale | English |
---|---|
Numero di pagine | 0 |
Rivista | Clinical Genitourinary Cancer |
Stato di pubblicazione | Published - 2019 |
All Science Journal Classification (ASJC) codes
- ???subjectarea.asjc.2700.2730???
- ???subjectarea.asjc.2700.2748???